0 NASDAQ Companies - May 13, 2024GOGL – Invitation to presentation of Q1 2024 ResultsGolden Ocean Group Limited (the “Company) will publish its financial results for the first quarter of 2024 on Wednesday May […]Read More
0 NASDAQ Companies - May 13, 2024NVIDIA Accelerates Quantum Computing Centers Worldwide With CUDA-Q PlatformHAMBURG, Germany, May 12, 2024 (GLOBE NEWSWIRE) — ISC — NVIDIA today announced that it will accelerate quantum computing efforts […]Read More
0 NASDAQ Companies - May 13, 2024NVIDIA Grace Hopper Ignites New Era of AI SupercomputingHAMBURG, Germany, May 12, 2024 (GLOBE NEWSWIRE) — ISC—Driving a fundamental shift in the high-performance computing industry toward AI-powered systems, […]Read More
0 NYSE Companies - May 13, 2024Caledonia Mining Corporation Plc Results for the Quarter ended March 31, 2024; Notice of Management Conference CallST HELIER, Jersey, May 13, 2024 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: […]Read More
0 NYSE Companies - May 13, 2024QIAGEN erhält FDA-Zulassung für syndromischen QIAstat-Dx-Test zur schnellen und präzisen Diagnose von AtemwegserkrankungenGERMANTOWN, Md. und VENLO, Niederlande, May 13, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurter Prime Standard: QIA) hat heute […]Read More
0 NYSE Companies - May 13, 2024QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate resultsGermantown, Maryland, and Venlo, the Netherlands, May 13, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today […]Read More
0 NASDAQ Companies - May 13, 2024Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with inadequately controlled […]Read More